157 related articles for article (PubMed ID: 21681103)
1. A randomised double-blind crossover trial of the potential analgesic effect of a transdermal nicotine patch in non-smokers based on objective and subjective assessment.
Fukada T; Iwakiri H; Ozaki M
Eur J Anaesthesiol; 2011 Aug; 28(8):592-6. PubMed ID: 21681103
[TBL] [Abstract][Full Text] [Related]
2. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study.
Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P
Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
[TBL] [Abstract][Full Text] [Related]
4. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study.
Hong D; Conell-Price J; Cheng S; Flood P
Anesth Analg; 2008 Sep; 107(3):1005-10. PubMed ID: 18713921
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
Poltavski DV; Petros T
Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
[TBL] [Abstract][Full Text] [Related]
6. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
7. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
Worrich S; Schuler G; Janicki PK
Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of intranasal nicotine and postoperative pain, nausea and vomiting in non-smoking women.
Jankowski CJ; Weingarten TN; Martin DP; Whalen FX; Gebhart JB; Liedl LM; Danielson DR; Nadeau AM; Schroeder DR; Warner DO; Sprung J
Eur J Anaesthesiol; 2011 Aug; 28(8):585-91. PubMed ID: 21562425
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
10. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
Poltavski DV; Petros T
Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
[TBL] [Abstract][Full Text] [Related]
12. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
13. Transdermal nicotine for analgesia after radical retropubic prostatectomy.
Habib AS; White WD; El Gasim MA; Saleh G; Polascik TJ; Moul JW; Gan TJ
Anesth Analg; 2008 Sep; 107(3):999-1004. PubMed ID: 18713920
[TBL] [Abstract][Full Text] [Related]
14. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
15. Transdermal nicotine alters some of marihuana's effects in male and female volunteers.
Penetar DM; Kouri EM; Gross MM; McCarthy EM; Rhee CK; Peters EN; Lukas SE
Drug Alcohol Depend; 2005 Aug; 79(2):211-23. PubMed ID: 16002030
[TBL] [Abstract][Full Text] [Related]
16. Effect of high-dose nicotine patch on the characteristics of lapse episodes.
Ferguson SG; Shiffman S
Health Psychol; 2010 Jul; 29(4):358-66. PubMed ID: 20658822
[TBL] [Abstract][Full Text] [Related]
17. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
19. Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers.
Min SK; Moon IW; Ko RW; Shin HS
Psychopharmacology (Berl); 2001 Dec; 159(1):83-8. PubMed ID: 11797074
[TBL] [Abstract][Full Text] [Related]
20. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
